REGN

REGN R&D to Revenue

40.79%Fiscal year

Period ending:

REGN FY R&D/Revenue%
REGN FY R&D/Revenue636.33%-68.18%
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

REGN r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Regeneron Pharmaceuticals R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
40.7881%
36.8469%
30.3929%
25.1058%
16.3138%
29.4112%
34.1543%
30.3675%
32.861%
40.0695%
37.665%
43.2219%
38.8999%
42.7003%
111.7984%
102.2853%
101.3835%
111.8562%
152.0716%
192.4788%
208.3634%
78.2079%
236.5758%
568.1554%
416.6022%
94.9052%
130.1449%
96.8586%
83.9879%
117.4274%
85.0365%
171.1207%
0%
0%
0%
0%

Compare r&d to revenue

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.